Résultats de la recherche - 7 results
Evaluating the health and health economic impact of the COVID-19 pandemic on delayed cancer care in Belgium: A Markov model study protocol
the evaluation of the impact of delayed cancer care caused by the COVID-19 pandemic in Belgium which can be used by researchers to respond to diverse research questions in a variety of disruptive ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.
this short summary presents the pathological basis and considers various questions related to screening for cervical cancer. As also reported in earlier reviews, the meta-analysis by Kleijnen Systematic ...
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
screening need to be identified. A systematic review was conducted to answer the question which hrHPV tests fulfil the criteria defined by an international expert team in 2009, based on reproducibility and ...
Évaluation du Plan Cancer 2008-2010: Septembre 2012
Le présent document évalue de manière détaillée l’impact de la mise en oeuvre duPlan Cancer 2008-2010 et tente d’apporter une réponse aux questions suivantes: Les objectifs liés au Plan Cancer ont-ils ...
BELGIAN CANCER BAROMETER 2020 Methodology for the working groups
comparisons will be made (European level). In addition to patients, other relevant stakeholders will be surveyed/ questioned on their perspectives concerning the previously stated domains and on their views on ...
CanCon European Guide on Quality Improvement in Comprehensive Cancer Control- Chapter 4: Screening
feasibility of fulfilling the national requirements in practice. In light of currently available evidence, some prostate cancer screening policies may be costeffective but questions remain on the optimal ...
Focus: Prévention et dépistage du cancer: Vaccination, dépistage, auto-prélèvement… Pour en finir avec le cancer du col, il y a encore du travail
Abstract: Marc Arbyn répond à nos questions sur le chemin qu’il reste à parcourir en Belgique pour améliorer la lutte contre le cancer du col de l’utérus et le virus à son origine, le human papillomavirus ...